EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Anti-VEGF Therapies in Retinal Disorders: Current Landscape and Future Directions

Jay Umed Sheth iD

Clinical Ophthalmology · 2026-04 · Volume 20 · 1-5

DOI: 10.2147/opth.s603279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Ophthalmology, 2026-04. Verfasst von Jay Umed Sheth. Beteiligte Einrichtung: Department of Retina Services, Shantilal Shanghvi Eye Institute, Mumbai, MH, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-vascular endothelial growth factor (anti-VEGF) therapy has transformed the management of macular neovascularization and other retinal vascular disorders; however, treatment burden, variable response, and cost continue to limit real-world outcomes. This Commentary presents an evidence synthesis from a curated collection of articles, focusing on three intersecting priorities: expanding access through biosimilars with comparable efficacy and safety profiles; optimizing treatment through individualized agent selection and faricimab switching paradigms; and leveraging quantitative multimodal imaging biomarkers, including advanced en-face optical coherence tomography fluid metrics, to refine disease monitoring and retreatment decisions. Emerging structural and angiographic biomarkers, including advanced en-face optical coherence tomography metrics, offer opportunities for earlier risk stratification and personalized care. In parallel, patient-centered considerations and pragmatic treatment algorithms remain essential to enhance adherence and durability of response. Together, these themes underscore a shift toward precision-guided, accessible, and evidence-based retinal care. Prospective validation and implementation research will be critical to translate these advances into sustainable clinical practice.

Schlagwörter

Stichwörter der Autor:innen

anti-vascular endothelial growth factorbiosimilarsmacular neovascularizationoptical coherence tomography

Autor:innen und Institutionen

  • Department of Retina Services, Shantilal Shanghvi Eye Institute, Mumbai, MH, India.

ORCID-Profile: Jay Umed Sheth

Zitieren

APA

Sheth, J. U. (2026). Anti-VEGF Therapies in Retinal Disorders: Current Landscape and Future Directions. Clinical Ophthalmology, Volume 20, 1-5. https://doi.org/10.2147/opth.s603279

Vancouver

Sheth JU. Anti-VEGF Therapies in Retinal Disorders: Current Landscape and Future Directions. Clinical Ophthalmology. 2026;Volume 20:1-5. doi:10.2147/opth.s603279

BibTeX
@article{Sheth2026,
  author = {Sheth, Jay Umed},
  title = {Anti-VEGF Therapies in Retinal Disorders: Current Landscape and Future Directions},
  journal = {Clinical Ophthalmology},
  year = {2026},
  volume = {Volume 20},
  pages = {1--5},
  doi = {10.2147/opth.s603279}
}
Kostenlos starten →